Correlation Between Alx Oncology and Mineralys Therapeutics

Can any of the company-specific risk be diversified away by investing in both Alx Oncology and Mineralys Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alx Oncology and Mineralys Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Alx Oncology Holdings and Mineralys Therapeutics Common, you can compare the effects of market volatilities on Alx Oncology and Mineralys Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alx Oncology with a short position of Mineralys Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alx Oncology and Mineralys Therapeutics.

Diversification Opportunities for Alx Oncology and Mineralys Therapeutics

0.17

Correlation Coefficient

Alx Oncology  Mineralys Therapeutics

Average diversification

The 3 months correlation between Alx and Mineralys is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding Alx Oncology Holdings and Mineralys Therapeutics Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mineralys Therapeutics and Alx Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alx Oncology Holdings are associated (or correlated) with Mineralys Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mineralys Therapeutics has no effect on the direction of Alx Oncology i.e., Alx Oncology and Mineralys Therapeutics go up and down completely randomly.

Pair Corralation between Alx Oncology and Mineralys Therapeutics

Given the investment horizon of 90 days Alx Oncology Holdings is expected to generate 1.43 times more return on investment than Mineralys Therapeutics. However, Alx Oncology is 1.43 times more volatile than Mineralys Therapeutics Common. It trades about 0.05 of its potential returns per unit of risk. Mineralys Therapeutics Common is currently generating about 0.0 per unit of risk. If you would invest  858.00  in Alx Oncology Holdings on January 31, 2024 and sell it today you would earn a total of  828.00  from holding Alx Oncology Holdings or generate 96.5% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	61.94%
Values	Daily Returns

Alx Oncology Holdings  vs.  Mineralys Therapeutics Common

Alx Oncology Holdings

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Alx Oncology Holdings are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Alx Oncology displayed solid returns over the last few months and may actually be approaching a breakup point.

Mineralys Therapeutics

Risk-Adjusted Performance

5 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Mineralys Therapeutics Common are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Mineralys Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Alx Oncology and Mineralys Therapeutics

The main advantage of trading using opposite Alx Oncology and Mineralys Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alx Oncology position performs unexpectedly, Mineralys Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mineralys Therapeutics will offset losses from the drop in Mineralys Therapeutics' long position.

The idea behind Alx Oncology Holdings and Mineralys Therapeutics Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.